[1]郭银树**.子宫腺肌病恶变再认识[J].中国微创外科杂志,2025,01(4):193-196.
点击复制

子宫腺肌病恶变再认识()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2025年4期
页码:
193-196
栏目:
专家笔谈
出版日期:
2025-04-25

文章信息/Info

作者:
郭银树**
(首都医科大学附属北京妇产医院妇科微创中心北京妇幼保健院,北京100006)
文献标志码:
C

参考文献/References:

[1]Machida H,Maeda M,Cahoon SS,et al.Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis:are these two different entities?Arch Gynecol Obstet,2017,295(6):1459-1468.
[2]Raffone A,Raimondo D,Maletta M,et al.Endometrial cancer arising in adenomyosis (EC-AIA):a systematic review.Cancers,2023,15(4):1142.
[3]袁航,张师前.子宫腺肌病恶变的诊治及注意事项.中国计划生育和妇产科,2019,11(4):12-14.
[4]Yuan H,Zhang S.Malignant transformation of adenomyosis:literature review and meta-analysis.Arch Gynecol Obstet,2019,299(1):47-53.
[5]李东林,梁文通.子宫腺肌病的特殊类型及恶变的诊治.中国实用妇科与产科杂志,2017,33(2):160-163.
[6]Oaknin A,Bosse TJ,Creutzberg CL,et al.Endometrial cancer:ESMO clinical practice guideline for diagnosis,treatment and follow-up.Ann Oncol,2022,33(9):860-877.
[7]Szubert M,Kozirog E,Wilczynski J.Adenomyosis as a risk factor for myometrial or endometrial neoplasms-review.Int J Environ Res Public Health,2022,19(4):2294.
[8]Raffone A,Travaglino A,Raimondo D,et al.Histological prognostic factors of endometrial cancer in patients with adenomyosis:a systematic review and meta-analysis.Pathobiology,2022,89(3):127-134.
[9]段拽林,魏丽军.波形蛋白和突变型P53在子宫内膜腺癌和浆液性癌中的表达研究.中国药物与临床,2020,20(21):3552-3554.
[10]Yoshida H,Asami Y,Kobayashi-Kato M,et al.Genetic features of endometrioid-type endometrial carcinoma arising in uterine adenomyosis.Virchows Arch,2021,481(1):117-123.
[11]Habiba M,Pluchino N,Petignat P,et al.Adenomyosis and endometrial cancer:literature review.Gynecol Obstet Invest,2018,83(4):313-328.
[12]Erkilinc S,Taylan E,Gülseren V,et al.The Effect of adenomyosis in myometrial invasion and overall survival in endometrial cancer.Int J Gynecol Cancer,2018,28(1):145-151.
[13]Stefanko DP,Eskander R,Aisagbonhi O.Disseminated endometriosis and low-grade endometrioid stromal sarcoma in a patient with a history of uterine morcellation for adenomyosis.Case Rep Obstet Gynecol,2020,2020:7201930.
[14]高阳,宋誌.子宫腺肌病恶变的研究进展,国际妇产科学杂志,2018,45(2):171-174.
[15]Bang YJ,Lee JM,Pyeon SY.Endometrial adenocarcinoma arising in adenomyosis:case report and review of literature.Eur J Gynaecol Oncol,2020,41(6):858-862.
[16]王海静,王悦,祝洪澜,等.子宫腺肌病恶变9例临床病理分析.中国妇产科临床杂志,2017,18(5):388-391.
[17]Chikumi J,Oishi T,Nakaso T,et al.Endometrial cancer arising in adenomyosis that could not be diagnosed by endometrial biopsy:a case report.Yonago Acta Med,2022,65(1):106-110.
[18]Moraru L,Mitranovici MI,Chiorean DM,et al.Adenomyosis and its possible malignancy:a review of the literature.Diagnostics,2023,13(11):1883.
[19]Nakai Y,Maeda E,Kanda T,et al.Uterine adenomyosis with extensive glandular proliferation:case series of a rare imaging variant.Diagn Interv Radiol,2020,26(3):153-159.
[20]Izumi Y,Yamamoto T,Matsunaga N,et al.Endometrial cancer arising from adenomyosis:case report and literature review of MRI findings.Radiol Case Rep,2020,15(4):427-430.
[21]Colman HI,Rosenthal AH.Carcinoma developing in areas of adenomyosis.Obstet Gynecol,1959,14:342-348.
[22]Chao X,Wu M,Ma S,et al.The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis:a pilot study.Sci Rep,2020,10(1):5984.
[23]Baba A,Yamazoe S,Dogru M,et al.Clear cell adenocarcinoma arising from adenomyotic cyst:a case report and literature review.J Obstet Gynaecol Res,2016,42(2):217-223.
[24]Talwar A,Behera P,Ahuja A,et al.Endometrial serous carcinoma arising from adenomyosis:a clinico-pathological insight.J Fam Reprod Health,2021,15(2):125-129.
[25]Talia KLF,Naaman YM,McCluggage WGF.Uterine adenosarcoma originating in adenomyosis:report of an extremely rare phenomenon and review of published literature.Int J Gynecol Pathol,2021,40(4):342-348.
[26]Sun Y,Lin S,Wu W,et al.Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)?A systematic review and meta-analysis.Int J Surg,2024,110(5):3072-3080.
[27]中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识.中华妇产科杂志,2020,55(6):376-383.
[28]Liu CH,Chang WH,Liu WM,et al.Serous carcinoma arising from adenomyosis.Taiwan J Obstet Gynecol,2017,56(5):706-707.
[29]Yang J,Wang Q,Han X,et al.Endometrioid adenocarcinoma arising from adenomyosis:two case reports and a literature review.Front Surg,2023,10:1142749.
[30]杨惠娟,于婷,韩旭.子宫腺肌病诊治及其与子宫内膜癌关系的研究进展.国际妇产科学杂志,2020,47(2):212-216.
[31]丁逸雯,李莉.子宫腺肌病与子宫内膜癌相关性的研究进展.癌症进展,2023,21(24):2681-2686.
[32]Aslan K,Sar? ME,Yal??n HR,et al.Coexistence of uterine adenomyosis is not associated with a better prognosis in endometrioid-type endometrial cancer.Ir J Med Sci,2020,189(3):835-842.

备注/Memo

备注/Memo:
基金项目:北京市自然科学基金面上项目(7232063)**通讯作者,Email:dgl1308@ccmu.edu.cn
更新日期/Last Update: 2025-06-17